Mg and its alloys have been identified as promising bone implant materials owing to their
natural degradability, good biocompatibility and favorable mechanical properties …

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the expansion
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …

Transplantation of hematopoietic cells from a healthy individual (allogeneic hematopoietic
cell transplantation (allo-HCT)) demonstrates that adoptive immunotherapy can cure blood …

Relapse of the original disease is a major cause of death after allogeneic hematopoietic cell
transplantation for acute leukemias. There is growing evidence that relapses may be …

HLA-haploidentical hematopoietic stem cell transplantation is now one of the most
commonly employed alternative donor techniques, with most centers applying T-cell–replete …

We conducted two parallel prospective, multicenter, phase II studies to evaluate the safety
and efficacy of HLA-haploidentical peripheral blood stem cell transplantation using post …

Patients with hematologic malignancies relapsing after allogeneic blood or marrow
transplantation (BMT) have limited response to conventional salvage therapies, with an …

With advances in allogeneic hematopoietic stem cell transplant (allo-HCT), disease relapse
has replaced transplant-related mortality as the primary cause of treatment failure for …

Over the last decade, the development of multiple strategies to allow the safe transfer from
the donor to the patient of high numbers of partially HLA-incompatible T cells has …

The curative potential of allogeneic hematopoietic cell transplantation (allo-HCT) in the
treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) …